Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time: A Multicenter, Randomized, Parallel-Controlled Study

NCT07661030 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT07661030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07661030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time: A Multicenter, Randomized, Parallel-Controlled Study
Lead sponsor
First Affiliated Hospital of Wenzhou Medical University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 30, 2026
Completion date
July 30, 2027
Enrollment
142 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gout